Assessments of the effect of Salmeterol and Fluticasone Propionate (SFC250) on the patients with chronic obstructive pulmonary disease by Impulse Oscillometry
Not Applicable
- Conditions
- Chronic Obstructive Pulmonary Disease
- Registration Number
- JPRN-UMIN000004196
- Lead Sponsor
- St. Marianna University School of Medicine, Division of Respiratory and Infectious Diseases
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patient is receiving inhaled steroids and long-acting beta2-agonists. 2. Patient is diagnosis as asthma. 3. Patient is decided as inappropriate for this study by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the additive effects of SFC250 on pulmonary functions (IOS, etc) of COPD patients treated by tiotropium on 4, 8,12weeks
- Secondary Outcome Measures
Name Time Method a) Improvement of clinical symptoms (dyspnea, cough, sputum) and QOL b) Reduction of the exacerbations (follow up to 52weeks) c) Adverse events